Propylhexedrine

Propylhexedrine
Clinical data
Trade names	Benzedrex, Obesin, Dristan Inhaler, and others
Other names	1-cyclohexyl-2-methylaminopropane
AHFS/Drugs.com	Monograph
Pregnancy; category	C;
Routes of; administration	Medical: Intranasal (inhaler); Recreational: Oral, parenteral
ATC code	N06BA ;
Legal status
Legal status	AU: S4 (Prescription only); BR: Class B1 (Psychoactive drugs); CA: Unscheduled; DE: Prescription Only; UK: P (Pharmacy medicines); US: OTC; UN: Unscheduled;
Pharmacokinetic data
Elimination half-life	4 ± 1.5 hours
Identifiers
	IUPAC name (±)-1-cyclohexyl-N-methylpropan-2-amine;
CAS Number	101-40-6 ; hydrochloride: 1007-33-6 ;
PubChem CID	7558;
DrugBank	DB06714 ;
ChemSpider	7277 ;
UNII	LQU92IU8LL; hydrochloride: 064LUN7NZ5 ;
KEGG	D05637 ;
CompTox Dashboard (EPA)	DTXSID1023526 ;
ECHA InfoCard	100.002.673
Chemical and physical data
Formula	C10H21N
Molar mass	155.285 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES N(C(CC1CCCCC1)C)C;
	InChI InChI=1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3 ; Key:JCRIVQIOJSSCQD-UHFFFAOYSA-N ;
	(what is this?) (verify)

Propylhexedrine, sold under the brand name Benzedrex among others, is an alkylamine primarily utilized as a topical nasal decongestant. Its main indications are relief of congestion due to colds, allergies, and allergic rhinitis. Propylhexedrine was first used medically in 1949, with the release of Benzedrex by Smith, Kline & French, and it has been used, mainly within the United States, since then.